Sign in
4

Changes in Ownership

Annexon, Inc. Filed Acc 0001567619-21-017166

EVP & Chief Scientific Officer sold 16,190 shares at $20.00 ($323,860)

  • EVP & Chief Scientific Officer acquired 16,190 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Yednock Ted EVP & Chief Scientific Officer 2021-09-13 Option exercise +15,000 $1.41 $21,144 15,000 D: show line 1 in the form
Yednock Ted EVP & Chief Scientific Officer 2021-09-13 Option exercise +1,190 $5.11 $6,081 16,190 D: show line 2 in the form
Yednock Ted EVP & Chief Scientific Officer 2021-09-13 Sale −16,190 $20.00 $323,860 0 D: show line 3 in the form
Open-market sales · 16,190 sh · avg $20.00 · $323,860

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Yednock Ted EVP & Chief Scientific Officer 2021-09-13 Option exercise · Stock Option (Right to Buy) −15,000 10,615 D: show line 4 in the form
Yednock Ted EVP & Chief Scientific Officer 2021-09-13 Option exercise · Stock Option (Right to Buy) −1,190 67,939 D: show line 5 in the form
Loading xslF345X03/doc1.xml…